ICH - Training on Q13 Guideline on Continuous Manufacturing of Drug Substances and Drug Product

2nd February 2023

ICH

The ICH Q13 Guideline on Continuous Manufacturing of Drug Substances and Drug Products reached Step 4 of the ICH Process on 16 November 2022.

Following the adoption of this Guideline, a Step 4 Introductory Training Presentation has been developed by the Q13 Expert Working Group.

View

Back to News Archive